Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-30

Clinical Trial Update: Study of 0417 Ointment in the Treatment of Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating 0417 Ointment for atopic dermatitis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0417 Ointment

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-30